Dartmouth-Hitchcock Health’s (D-HH) Department of Anesthesiology and Perioperative Medicine is pleased to host a two-part session focused on the science, safety, and efficacy of mRNA COVID vaccines and the state’s and D-HH’s distribution and allocation plans.
Kathryn Stephenson, MD, MPH, Director of the Clinical Trials Unit at the Harvard Center for Virology and Vaccine Research and an infectious disease physician, discusses the biologic basis of COVID vaccine development, as well as the clinical trials process. She also addresses concerns about the rigors of testing and the likelihood of sustained immunity in addition to potential complications.
Laura Chiang, MD, moderates the series. Dr. Chiang is the Vice Chair for Education in the Department of Anesthesiology and the Co-Medical Director of the Surgical Intensive Care Unit.
Two of D-HH’s own infectious disease doctors join Dr. Chiang for the series. Elizabeth Talbot, MD, the NH state deputy epidemiologist, and Michael Calderwood, MD, MPH, Associate Chief Quality Officer at D-HH, assist in fielding questions from participants in this session and will present in Part Two of the series on Monday, December 21, 2020.
This session was recorded via Zoom on Friday, December 18, 2020.
